Paper19508
Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
Greenblatt DJ and 5 others. J Clin Pharmacol, 1977. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results. Papers, record 19508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19508
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Lorazepam | Major topic |
| Adult | |
| Glucuronates | |
| Half-Life | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Models, Biological |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,033,903 | Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and Zidovudine. | AAPS J | 2020 | https://conductscience.org/library/papers/33033903 | PubMed |
| 23,344,790 | A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam. | AAPS J | 2013 | https://conductscience.org/library/papers/23344790 | PubMed |
| 22,050,870 | Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus. | J Pediatr | 2012 | https://conductscience.org/library/papers/22050870 | PubMed |
| 20,218,012 | Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/20218012 | PubMed |
| 18,749,215 | Neurology-important advances in clinical medicine: Lorazepam: a new antiepileptic drug in status epilepticus therapy. | West J Med | 1982 | https://conductscience.org/library/papers/18749215 | PubMed |
| 17,635,501 | Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions. | Br J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/17635501 | PubMed |
| 6,111,408 | Clinical pharmacokinetics of oxazepam and lorazepam. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/6111408 | PubMed |
| 2,822,333 | Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/2822333 | PubMed |
| 1,745,715 | Dose-dependent effects of intravenous lorazepam on cardiovascular activity, plasma catecholamines and psychological function during rest and mental stress. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/1745715 | PubMed |
| 43,806 | The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. | Eur J Drug Metab Pharmacokinet | 1979 | https://conductscience.org/library/papers/43806 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19508
GET https://conductscience.org/api/papers/v1/19508/authors